Anticoagulation to prevent stroke in atrial fibrillation. It's still not clear whether results in secondary care translate to primary care

Clinical Trial

D A Fitzmaurice et al. BMJ. 2000.

. 2000 Nov 4;321(7269):1156.

No abstract available

Comment on

Anticoagulation for patients with atrial fibrillation and risk factors for stroke. Warfarin reduces the risk by two thirds, but doctors still aren't prescribing it enough.
Connolly SJ. Connolly SJ. BMJ. 2000 May 6;320(7244):1219-20. doi: 10.1136/bmj.320.7244.1219. BMJ. 2000. PMID: 10797015 Free PMC article. No abstract available.
Prospective cohort study to determine if trial efficacy of anticoagulation for stroke prevention in atrial fibrillation translates into clinical effectiveness.
Kalra L, Yu G, Perez I, Lakhani A, Donaldson N. Kalra L, et al. BMJ. 2000 May 6;320(7244):1236-9. doi: 10.1136/bmj.320.7244.1236. BMJ. 2000. PMID: 10797031 Free PMC article.

1. Kalra L, Yu G, Perez I, Lakhani A, Donaldson N. Prospective cohort study to determine if trial efficacy of anticoagulation for stroke prevention in atrial fibrillation translates into clinical effectiveness. BMJ. 2000;320:1236–1239. . (6 May.) - PMC - PubMed
1. Copland M, Tait RC, Walker ID. A retrospective follow-up study of oral anticoagulant control and haemorrhagic complications in an elderly population with atrial fibrillation. Br J Haematol. 2000;08(S1):56.
1. Connolly SJ. Anticoagulation for patients with atrial fibrillation and risk factors for stroke. BMJ. 2000;320:1219–1220. . (6 May.) - PMC - PubMed
1. Kalra L, Yu G, Perez I, Lakhani A, Donaldson N. Prospective cohort study to determine if trial efficacy of anticoagulation for stroke prevention in atrial fibrillation translates into clinical effectiveness. BMJ. 2000;320:1236–1239. . (6 May.) - PMC - PubMed
1. Oswald N, Bateman H. Applying research evidence to individuals in primary care: a study using non-rheumatic atrial fibrillation. Fam Pract. 1999;16:414–419. - PubMed